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Whereas we found striking improvement with hydroxocobalamin in many of our cases, equal improvement was seen in others with cyanocobalamin, corticotrophin, or prednisolone, or spontaneously. Spontaneous recovery in optic neuritis is well known (Traquair, 1957; Walsh, 1957) . Of the three patients with bilateral centrocaecal scotomata simulating tobacco amblyopia, one improved on corticotrophin alone, while another started improving spontaneously before hydroxocobalamin was given.
Hence two conclusions can justifiably be drawn from our cases.
(1) That tobacco amblyopia is rare in this part of India in spite of a large population of vegetarian smokers. This is the more interesting in view of the fact that in the control series vegetarian smokers had high plasma thiocyanate levels and the lowest serum B1, levels in the population. (2) That smoking, vegetarianism, and vitamin B1, (either as hydroxocobalamin or as cyanocobalamin) play no part in the pathogenesis of isolated "idiopathic" optic neuritis as seen in our patients.
lating hormone-releasing hormone (LH/FSH-RH), have been studied in 18 normal men and five women in the follicular phase of their menstrual cycle. Rapid and dosedependent (25 to 100 tg) increases in serum immunoreactive LH were seen, which reached a peak 20 to 30 minutes after a rapid intravenous injection. Similar but much smaller increases in serum immunoreactive FSH were seen. These conclusions have been validated by using two different immunoassay systems for each hormone. The LH/FSH-RH therefore causes both LH and FSH release in man as in animals but does not affect growth hormone, thyrotrophin, or ACTH. The gonadotrophin responses were the same in the women as in the men but were insufficient in the men to cause statistically significant changes in the serum levels ofthe gonadal steroid hormones, testosterone or oestradiol, or in their precursors 17 z-hydroxyprogesterone or progesterone. In the women, however, there was a rise in oestradiol after the 100-Lg doses. The use of LH/FSH-RH will provide an important test to define the level of the lesion in hypogonadal patients and also should be valuable in the treatment of some types of male and female in- (McCann and Dhariwal, 1964; McCann and Dhariwal, 1966 ), but it has proved possible to isolate only one purified polypeptide from these extracts (Schally et al., 1971a (Schally et al., , 1971b . This decapeptide, pyro -GLU -HIS -TRP -SER-TYR -GLY-LEU-ARG -PRO -GLY-NH, (Matsuo et al., 1971) , obtained from pig hypothalami, has now been synthesized and it appears to release both LH and FSH from the pituitaries of animals (Schally, et al., 1971c Three dose levels of LH/FSH-RH were used-25, 50, and 100 ptg given as a rapid intravenous injection in 1, 2, or 4 ml of saline respectively at 10 a.m. Six men each received two dose levels at seven-day intervals, either 25 and 50 ,ug or 50 and 100 u±g or 25 and 100 ,ug in random order, through an indwelling forearm venous cannula inserted under local anaesthesia 60 minutes before the injection. Two women each received 50 and 100 ,ug during the follicular phases of subsequent cycles (between days 3 and 10). Blood was drawn 15 minutes and immediately before the injection and then at intervals afterwards for 48 hours. The cannulae were withdrawn after two hours and subsequent samples were obtained by venepuncture.
The following hormones were determined: LH and FSH (in two different radioimmunoassays), growth hormone (GH), thyrotrophin (TSH), cortisol as a measure of ACTH secretion, and the gonadal steroid hormones testosterone, oestradiol, 17ax-hydroxyprogesterone, and progesterone, as well as the total 17 P-hydroxyandrogens.
LIMITED STUDY
A dose of 100 jig was given intravenously to 14 further normal men and to three women between days three and six of their menstrual cycle, and blood was obtained for LH and FSH assay before and at 20 and 60 minutes afterwards.
Assay Methods.-LH and FSH were each assayed in duplicate in each of two separate systems, the characteristics of which are shown in Table I . Both assays used a second antibody method to separate bound and free hormones. Details of the radioimmunoassays for GH and TSH and for the competitive protein binding method for 17,-hydroxyandrogens (Anderson, 1970) and fluorogenic corticosteroids are given elsewhere.
Plasma Gonadal Steroids.-Progesterone, 17 x-hydroxyprogesterone, testosterone, and oestradiol were extracted with diethyl ether from separate aliquots of plasma (5 ml total), separated from closely related steroids on columns of Sephadex LH20, and determined by radioimmunoassay using antisera to progesterone-li ot-hemis ucinate-BSA, 17 o-hydroxyprogesterone-3-oxime-BSA, testosterone-3-oxime-BSA, and oestradiol-6-oxime-BSA (Collins, 1972) .
Results

INTENSIVE STUDY
The basal values for each hormone were taken to be the mean of the values determined from the samples obtained 15 25 ,ug and about eight hours after 50 and 100 ,ug. There are no essential differences between the LH results obtained in the two assay systems. With one exception after a 25-ig dose each subject on each dose showed a rise in serum LH level which exceeded the upper limit of the normal range (assay 1 :6-9 mU/ml, assay 2:4-6 mU/ml). The FSH levels showed similar but much smaller initial changes compared with the LH results. With assay 1 (Fig. 3 ) a significant rise was seen with each dose and there was a definite dose-response relationship. However, in every subject the increase in serum FSH was small and in no case did the response exceed the upper limit of the normal male range (4 5 mU/ml). With assay 2 (Fig. 4) 
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Gonadal Steroids.-There were no statistically significant changes in any of the four specific gonadal steroid hormones assayed in the male subjects, and this was also true for plasma 17,p-hydroxyandrogens on any dose. The results after 100 tLg LH/FSH-RH are shown in Fig. 5 , and there is a trend suggesting that the plasma testosterone is rising 24 to 48 hours after the dose. In the women plasma oestradiol rose from basal values of 84 and 68 pg/ml in the two subjects to reach a peak value of 105 and 115 pg/ml four and eight hours after injection of 100 [±g LH/FSH-RH. This was in response to increases of 4-5 and 6-9 in LH, 2-2 and 3-7 FSH mU/ml in the first subject (assays 1 and 2 respectively); and of 7-0 and 2-0 LH, 0 7 and 0 7 FSH mU/ml in subject 2; there were no significant changes in the other gonadal steroids in the women at this dose and none at all after 50 jig. Serum GH, TSH, and plasma cortisol did not change significantly in any subject after any dose.
LIMITED STUDY
After the initial study a standard LH/FSH-RH test procedure was adopted: 100 lAg was injected intravenously between 9 and 10 a.m. and blood was sampled before and 20 and 60 minutes afterwards for LH and FSH. Our provisional normal ranges for this test are given in Tables III and IV. Side Effects.-None were encountered in any subject and the menstrual cycles after administration of LH/FSH-RH were unaltered. There is no doubt that serum immunoreactive FSH also rose in response to LH/FSH-RH since the increments seen could not be accounted for by any cross-reactivity of the antisera used in either assay. We have therefore confirmed that this hormone releases FSH as well as LH but that it does not affect any of the other non-gonadotrophin pituitary hormones studied, GH, TSH, or ACTH. However, the rise in FSH is much smaller than that of LH, and of the 32 occasions that the substance was administered serum FSH failed to rise outside the normal range 24 times. It remains to be determined whether there is another more specific FSH-releasing hormone or whether the release of LH or FSH depends on the interaction of circulating gonadal hormone levels and the known LH/FSH-RH.
There appear to be no differences between the gonadotrophin responses to LH/FSH-RH in the men or women studied during the follicular phases of their cycles. Preliminary results, however, suggest that much bigger responses in both LH and FSH can be obtained in women during the luteal phases compared with the follicular phases.
In the male subjects there were no statistically significant changes in the circulating gonadal steroid hormones, testosterone and oestradiol, or in their precursors, 17a-hydroxyprogesterone or progesterone, in response to the induced LH and FSH release. The upward trend in plasma testosterone at 48 hours after 100 ,ug LH/FSH-RH suggests that more prolonged gonadal stimulation is required to get a definite response, and either larger doses or different methods of administration of LH/FSH-RH will be necessary. In the women, however, after 100 jig of the releasing hormone definite increases in oestradiol were seen, indicating significant follicular stimulation. Further study will indicate the doses required to induce ovulation.
The availability of LH/FSH-RH should provide a powerful therapeutic agent for the treatment of infertility in many women and men. In addition it will provide a useful test of pituitary function in a manner analagous to the use of thyrotrophin-releasing hormone Ormston, et al., 1972) Recently Schally et al. (1971) showed that a purified extract of pig hypothalami (LH-RH) has both LH and FSH releasing properties in rats. H-uman subjects given this purified porcine LH-RH also release LH and FSH (Kastin et al., 1971) , as do monkeys, sheep, and rabbits (Reeves et al., 1970; Schally et al., 1970) . Kastin et al. (1970) also isolated two fractions from human hypothalami with LH-RH and FSH-RH activity, and when given separately both produced a significant increase in FSH and LH after administration to volunteers. Schally et al. (1971) proposed a provisional structure for porcine LH-RH, which was revised and found to be a decapeptide (Matsuo et al., 1971) . A product with this amino-acid sequence has now been manufactured by Hoechst Pharmaceuticals and was used in the present study. 5, 10, 15, 20, and 30 minutes; and 1, 11, 2, 3, 6, 9, and 24 hours.
The blood samples were centrifuged immediately, the plasma being separated and deep frozen at -25°C until assayed. FSH and LH were determined by radioimmunoassay using a pituitary standard LER 907 (Wide and Porath, 1966) and oestradiol-17 , by radioimmunoassay using an anti-serum to oestradiol-6-carboxymethyl oxime-bovine serum albumin (Emment et al., 1972) .
The first six patients had oligomenorrhoea with cycles of six to eight weeks. These patients do not have the premenstrual rise in LH and FSH (Newton, 1972c; Ross et al., 1970) which occurs in the normal menstrual cycle (Newton et al., 1971a) ; the injection of LH-RH was given on the first day of bleeding. The last four patients had secondary amenorrhoea for not less than six months and had previously been investigated to assess their basal endocrine state (Newton 1972a (Newton , 1972b .
Results
The data in Tables I and II show the first significant rise of LH and FSH after the injection of synthetic LH-RH, the time at which the peak level was reached, the duration of raised gonadotrophin )evels, and the factorial increase of LH and FSH over the mean basal sample (mean of three). As can be seen from Table I there was a rise in LH in all 10 patients. Three showed the first significant rise 5 minutes after the injection, five after 10 minutes, and two after 15 minutes. The peak value for LH was reached after 30 minutes in four patients, 45 in two patients, and 90 minutes in two patients. The duration of response varied from 45 minutes to 8 hours 50 minutes, with five patients between 2 hours 50 minutes and 2 hours 55 minutes. The
